Keyphrases
Acute Respiratory Infection
8%
Adult Asthma
29%
Airway
11%
Airway Disease
7%
Airway Obstruction
11%
Allergy
17%
Allergy Diagnosis
9%
Anti-IgE
9%
Anti-IL-5
10%
Aspirin Hypersensitivity
6%
Associated Symptoms
8%
Asthma
100%
Asthma Control
17%
Asthma Diagnosis
16%
Asthma Hospitalization
13%
Asthma Onset
8%
Asthma Outcomes
7%
Asthma Patients
13%
Asthma Research
20%
Asthma Symptoms
14%
Asthmatic
14%
Atopic Asthma
7%
Autoantibodies
13%
Biologic Initiation
13%
Biologic Response
8%
Biologic Therapy
9%
Biological Treatment
9%
Biomarker Stability
6%
Blood Eosinophil Count
13%
Bronchoconstriction
13%
Celiac Disease
21%
Chronic Cough
8%
Chronic Obstructive Pulmonary Disease
24%
Chronic Rhinosinusitis
7%
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
13%
Comorbidity
23%
Confidence Interval
8%
Corticosteroid Exposure
6%
Corticosteroid Use
6%
Cough
11%
Cross-country Skiers
19%
Dermatitis Herpetiformis
13%
Diabetes
8%
Disease Burden
7%
Dry Powder Inhaler
6%
Dust Exposure
7%
Dyspnea
10%
Environmental Determinants
6%
Exacerbation Rate
16%
Finland
66%
Finnish Population
14%
Forced Expiratory Volume in 1 Second (FEV1)
32%
Foundry Workers
13%
Fractional Exhaled Nitric Oxide (FeNO)
16%
Health-related Quality of Life
10%
Healthcare Resource Utilization
10%
High Dose
7%
Home Mechanical Ventilation
6%
Hospitalization
14%
Idiopathic Pulmonary Fibrosis
13%
Inhaled Corticosteroids
24%
Interstitial Lung Disease
20%
Long-term Cohort Study
6%
Low Prevalence
6%
Lung Function
23%
Moisture Damage
13%
Multidisciplinary Approach
8%
Multiple Chemical Sensitivity
12%
Nordic Countries
13%
Obstructive Airway Disease
7%
Odds Ratio
8%
Older Adults
7%
Oral Corticosteroids
33%
Orthopedic Infection
6%
Pathophysiology
8%
Peak Expiratory Flow
13%
Plasma Cells
7%
Pneumonia
7%
Population-based
14%
Prolonged Cough
6%
Pulmonary Disease
7%
Quality Registry
6%
Research Cohort
19%
Respiratory Symptoms
25%
Risk Factors
8%
Severe Asthma
82%
Severe Uncontrolled Asthma
8%
Sinus Imaging
6%
Skiers
16%
Skin Diseases
8%
Standardized Incidence Ratio
8%
Sweden
24%
T2-low
13%
Tampere
10%
Transglutaminase 2
6%
Treatment Response
9%
Tumor
6%
Type 2 Inflammation
14%
Workplace
13%
Wound Registry
7%
Medicine and Dentistry
Aminolevulinic Acid
6%
Aminolevulinic Acid Hexyl Ester
6%
Aminolevulinic Acid Methyl Ester
6%
Asthma
89%
Autoinjector
6%
Basal-Cell Carcinoma
9%
Biological Marker
9%
Biological Product
40%
Biological Therapy
9%
Bloodstream Infection
6%
Bronchoconstriction
6%
Cancer Risk
6%
Case-Control Study
6%
Chronic Cough
8%
Chronic Obstructive Pulmonary Disease
18%
Chronic Rhinosinusitis
22%
Cigarette Smoking
6%
Clinical Finding
7%
Coeliac Disease
13%
Cohort Analysis
26%
Comorbidity
19%
Coughing
21%
Dermatitis Herpetiformis
6%
Diagnosis
7%
Disease Burden
9%
Diseases
21%
Dyspnea
11%
Epinephrine
6%
Forced Expiratory Volume
12%
Functional Endoscopic Sinus Surgery
6%
Genetic Screening
6%
Hantavirus
6%
Health Care
6%
Health Care Cost
5%
Ichthyosis
6%
Idiopathic Pulmonary Fibrosis
13%
Immunoglobulin E
11%
Infection
8%
Interstitial Lung Disease
20%
Kidney Graft
6%
Low Drug Dose
6%
Lung
16%
Lung Cancer
6%
Multiple Chemical Sensitivity
5%
Nasal Polyp
18%
Neoplasm
6%
Noninvasive Ventilation
6%
Observational Study
6%
Odds Ratio
7%
Orthopedic Implant
6%
Paranasal Sinus
6%
Pathophysiology
7%
Patient Referral
6%
Peak Expiratory Flow
6%
Pediatrics
9%
Photochemotherapy
6%
Phototherapy
6%
Population
5%
Prevalence
15%
Psoriasis
7%
Pyoderma gangrenosum
6%
Quality of Life
14%
Randomized Controlled Trial
5%
Respiratory Disease
7%
Retrospective Cohort Study
6%
Retrospective Study
6%
Severe Asthma
59%
Silo-Filler's Disease
7%
Skin Cancer
6%
Skin Carcinoma
6%
Skin Transplantation
6%
Standardized Incidence Ratio
10%
Symptomatic Treatment
13%
Treatment Response
9%
Ulcer
6%
Vascular Disease
6%
Venous Ulcer
6%
Volume CT
6%
Wound
13%